SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,633,410 | +5.8% | 71,221 | -0.0% | 0.01% | +14.3% |
Q2 2023 | $8,159,435 | -16.9% | 71,249 | +0.0% | 0.01% | -22.2% |
Q1 2023 | $9,817,217 | +1687.3% | 71,227 | +1580.3% | 0.01% | +800.0% |
Q4 2022 | $549,290 | +16.9% | 4,239 | -0.3% | 0.00% | – |
Q3 2022 | $470,000 | +51.1% | 4,250 | +2.5% | 0.00% | – |
Q2 2022 | $311,000 | +40.1% | 4,145 | +46.0% | 0.00% | – |
Q1 2022 | $222,000 | -96.5% | 2,840 | -92.5% | 0.00% | -100.0% |
Q4 2020 | $6,424,000 | -31.3% | 37,779 | -38.6% | 0.01% | -36.4% |
Q2 2019 | $9,345,000 | +30.7% | 61,500 | +2.5% | 0.01% | +22.2% |
Q1 2019 | $7,151,000 | +5.6% | 60,000 | -3.3% | 0.01% | 0.0% |
Q4 2018 | $6,772,000 | -68.1% | 62,053 | -52.8% | 0.01% | -62.5% |
Q3 2018 | $21,247,000 | +21.6% | 131,553 | -0.5% | 0.02% | +26.3% |
Q2 2018 | $17,477,000 | +837.1% | 132,220 | +425.1% | 0.02% | +850.0% |
Q1 2018 | $1,865,000 | +88.6% | 25,178 | +41.6% | 0.00% | +100.0% |
Q4 2017 | $989,000 | -12.8% | 17,775 | -28.9% | 0.00% | 0.0% |
Q3 2017 | $1,134,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |